Articles from Verasonics, Inc.

Verasonics, Inc., the leader in research ultrasound, today announced the release of new systems and features for the Vantage NXT Research Ultrasound Platform to advance ultrasound research and product development. New enhancements include Vantage NXT 32LE and 64 System configuration models and Acquisition SDK Option features. This release will be available to all Vantage NXT customers today.

Verasonics, Inc., the leader in research ultrasound, today announced a partnership with PhotoSound® Technologies, Inc. of Houston, TX to offer customers the PhotoSound Legion™ AMP for use with Vantage® and Vantage NXT Research Ultrasound Systems. Partnership will offer Vantage customers expanded capabilities by integrating the Legion AMP128 in applications using photoacoustic imaging, thermoacoustic imaging, and monitoring radiation therapy, among others.

Verasonics, Inc., the leader in research ultrasound, today announced the release of new features for the Vantage NXT Research Ultrasound System to advance ultrasound research and product development. The Vantage NXT update includes the release of the Acquisition SDK Programming Model and a 3 MHz matrix array transducer. This release will be available to all Vantage NXT customers on March 20, 2025.

Verasonics, Inc., the leader in research ultrasound, today announced the introduction of the Essentials of Ultrasound Imaging (EoUSI) Course – a ready-to-teach comprehensive educational solution that provides a curriculum similar to what is offered in a graduate-level ultrasound course at an academic institution or commercial organization.

Verasonics, Inc., the leader in research ultrasound, today announced that on September 17, 2024, the United States Patent and Trademark Office issued US patent number 12,089,991, “Ultrasound Transmitter with Low Distortion and Concurrent Receive,” covering an ultrasonic transceiver design providing the ability to transmit high power and high frequency arbitrary waveforms with low image distortion, and enabling concurrent receive and monitoring of the transmit signal through the receiver during the transmit period. This is one of many Verasonics patents issued worldwide covering ten unique technologies.

Verasonics, Inc., the leader in research ultrasound, today announced the release of new features and functionality for the Vantage NXT Research Ultrasound System. The Vantage NXT is the successor to Verasonics’ pioneering and industry-leading Vantage Research Ultrasound System.

Verasonics, Inc., the leader in research ultrasound, today announced the launch of the Verasonics Certified Consultant Program. This program is designed to offer customers additional consultative services beyond the standard customer support currently offered by the Company. These services include extensive product development projects, as well as related activities often dictated by rapid product development needs.

Verasonics, Inc., the leader in research ultrasound, announces a new OEM Supply Model to enhance corporate commercialization efforts for customers bringing ultrasound-based solutions to market. Verasonics’ commercial suite of solutions now offers the Commercial Technology Licensing Model and the OEM Supply Model. Both use Verasonics’ industry-leading technology to assist corporate customer development and commercialization efforts.

Verasonics, Inc., the leader in research ultrasound, today announced the expansion of its management team with the appointments of Christian Coviello, Ph.D. as Director of Ultrasound Science, and Andrew Lundberg as Director of Hardware Engineering and Operations. These strategic leadership additions to the management team affirm Verasonics strong focus on the importance of innovation advancement in research ultrasound.

Verasonics, Inc., the leader in research ultrasound, today announced it will launch the Vantage NXT, the successor to Verasonics’ industry-leading Vantage Research Ultrasound System. The Vantage NXT Research Ultrasound System features a proprietary transceiver design that was specifically engineered to provide the next level of transmit and receive fidelity required for cutting-edge ultrasound research. Researchers will gain access to several enhancements including expanded frequency bandwidth, enhanced arbitrary waveform generation and improved high frequency performance and imaging. Vantage NXT also provides a new integrated help system for improved ease of use.

Verasonics, Inc., the leader in research ultrasound, today announced it has enhanced the Vantage Research Ultrasound System with the introduction of the Verasonics Permissive License and new transducers, including a 15 MHz Row-Column Array and three general imaging transducers. This Vantage software update is available today, August 15, 2023, at no cost to customers.

Verasonics, Inc., the leader in research ultrasound, announced today that it has expanded its Scientific Advisory Board (SAB) to include nine additional members with valuable expertise in the fields of biomedical engineering and Materials Science. These thought leaders will work closely with the Verasonics leadership team and existing SAB membership to provide external scientific review and insight on existing and emerging technologies, as well as potential research and development programs.

Verasonics, Inc., the leader in research ultrasound, today announced that it has expanded its leadership team with the appointment of Don Christopher, Ph.D. as Chief Technology Officer (CTO) and Stacy Douthitt as Chief Business Officer (CBO). In addition, the company has added Alex Exposito as Director of Commercial Sales. Ken Linkhart, Verasonics’ former CTO, is continuing with Verasonics as the organization’s first Technical Fellow.

Verasonics, Inc., the leader in research ultrasound, today announced that since February 2021, Verasonics has received six new patents supporting the Company’s vision to advance research and development in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics.